Skip to content

Discontinued — last reported Q4 '22

Net margin at other companies

Pfizer logo
PfizerPFE
15.7%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-111.9%-51.5pp
AbbVie logo
AbbVieABBV
5.8%-1.5pp
Immunome logo
ImmunomeIMNM
-5,593.8%-11,284pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-156.4%-47.5pp
Incyte logo
IncyteINCY
26.7%+26.2pp

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$1.78B+674%
Enterprise value$1.68B+826%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
FCF margin-300.5%

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0.0×
Current ratio17.2×+12.6×

Where this comes from

Calculated from SELLAS Life Sciences Group, Inc.’s reported figures.

Based on trailing twelve months.

The official record: SELLAS Life Sciences Group, Inc.’s 10-K, filed March 28, 2024, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s net margin?
SELLAS Life Sciences Group, Inc. (SLS) reported net margin of -4,130.1% in Q4 2022.
How has SELLAS Life Sciences Group, Inc.'s net margin changed year-over-year?
SELLAS Life Sciences Group, Inc.'s net margin decreased by 1416.4% year-over-year, from -272.4% to -4,130.1%.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s net margin?
Over 2 years (2020 to 2022), SELLAS Life Sciences Group, Inc.'s net margin has grown at a 116.4% compound annual growth rate (CAGR), from -881.9% to -4,130.1%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.